IP Verse

Human Anti-Alpha-Synuclein Antibodies - EP2949666B1

PatentPatent Analysis

EP2949666

BIOGEN NEUROSCIENCE
Application Number
EP15166032A
Filing Date
Dec 21, 2009
Status
Revoked
Feb 2, 2024
Grant Date
Dec 19, 2018
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2949666B1 was granted to Biogen Neuroscience on Dec 19, 2018 following the initial filing on Dec 21, 2009 under the application number EP15166032A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MERCK SHARP & DOHMESep 19, 2019ADMISSIBLE
GLEISS GROSSE SCHRELL UND PARTNER MBBSep 18, 2019ADMISSIBLE
BREUERSep 17, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents